Ledger.Open graph →
SEC Form D · filed March 21, 2025

Acurx Pharmaceuticals, Inc

Offering
$3.4M
Sold
$3.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
STATEN ISLAND, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Robert G. Shawah · Staten Island, NYExecJoseph H. Scodari · Staten Island, NYDirectorDavid P. Luci · Staten Island, NYExecJames H. Donohue · Staten Island, NYDirectorRobert J. Deluccia · Staten Island, NYExec · DirectorThomas H. Harrison · Staten Island, NYDirectorCarl H. Sailer · Staten Island, NYDirectorJack H. Dean · Staten Island, NYDirectorDavid P. Luci · Staten Island, NYExecCarl H. Sailer · Staten Island, NYDirectorJoseph H. Scodari · Staten Island, NYDirectorJack H. Dean · Staten Island, NYDirectorJames H. Donohue · Staten Island, NYDirectorRobert G. Shawah · Staten Island, NYExecThomas H. Harrison · Staten Island, NYDirectorRobert J. Deluccia · Staten Island, NYExec · DirectorGraham Weaver · Arlington, VAExecDavid Fulcher · Arlington, VADirectorJoseph Palumbo · Vancouver, British Columbia, CanadaDirectorJordan Schmidt · Ventura, CADirectorCarol Scott · Los Angeles, CADirectorMichael M. Ritz · Atlanta, GAExec · DirectorDF Capital TR, LLC · Atlanta, GADirectorKanya Hasegawa · Singapore, U0Exec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗